Groundbreaking research that dares to challenge the pharmaceutical industry's status quo could be published anonymously, following in the footsteps of the Bitcoin whitepaper's pseudonymous author, Satoshi Nakamoto. Leveraging technologies like the Nostr protocol, the research community can build a system that ensures the permanence, integrity, and impartiality of the scientific record for generations to come.